Dave's Hot Chicken, a fast-growing LA-based chain, sells 75% stake to Roark Capital for nearly $1 billion, aiming for rapid domestic and global expansion.
Russia and Ukraine agree to major prisoner exchange, but fail to reach broader ceasefire deal
Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
Dave's Hot Chicken, a fast-growing LA-based chain, sells 75% stake to Roark Capital for nearly $1 billion, aiming for rapid domestic and global expansion.
Russia and Ukraine agree to major prisoner exchange, but fail to reach broader ceasefire deal
Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
